Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Therapeutics and Clinical Risk Management


Archive: Volume 3, 2007


Montelukast in the management of allergic rhinitis

Jaime A Lagos, Gailen D Marshall

Therapeutics and Clinical Risk Management 2007, 3:327-332

Published Date: 15 May 2007

Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B

Eugene B Kern, David Sherris, Angelos M Stergiou, Laura M Katz, Lisa C Rosenblatt, Jens Ponikau

Therapeutics and Clinical Risk Management 2007, 3:319-325

Published Date: 15 May 2007

Skin and skin structure infections: treatment with newer generation fluoroquinolones

Philip Giordano, Kurt Weber, Gail Gesin, Jason Kubert

Therapeutics and Clinical Risk Management 2007, 3:309-317

Published Date: 15 May 2007

Infliximab in the treatment of Crohn’s disease

Gilberto Poggioli, Silvio Laureti, Massimo Campieri, Filippo Pierangeli, Paolo Gionchetti, et al

Therapeutics and Clinical Risk Management 2007, 3:301-308

Published Date: 15 May 2007

Darbepoetin alpha in the treatment of cancer chemotherapy-induced anemia

Alberto Grossi, Francesca Balestri, Simone Santini

Therapeutics and Clinical Risk Management 2007, 3:269-275

Published Date: 15 May 2007

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

Jean-Pierre Armand, Vincent Ribrag, Jean-Luc Harrousseau, Lauren Abrey

Therapeutics and Clinical Risk Management 2007, 3:213-224

Published Date: 15 May 2007

Editorial || FREE PAPER ||

Garry M Walsh

Therapeutics and Clinical Risk Management 2007, 3:211-212

Published Date: 15 May 2007